Skip to main content
 

Genomic Biomarkers and Precision Oncology

Genomic Biomarkers and Precision Oncology


The Genomic Biomarkers and Precision Oncology Group (GBPrO_IIBM) is interested in the identification and characterization of prognostic and predictive markers and in the definition of new susceptibility genes mainly, but not exclusively, in ovarian cancer. We have an eminently translational approach with the ultimate goal of improving patient survival and quality of life through the application of our findings in the medical setting.
Main specialization